Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024
Project: HYPOXIMMUNO
Updated at: 27-04-2024